Variation in Delivery of Palliative Radiotherapy to Persons Dying of Cancer in Nova Scotia, 1994 to 1998 PURPOSE: To evaluate the tolerance and efficacy of intra-arterial (IA) cisplatin boost with ...

Women with early-stage breast cancer who are at high risk for the cancer coming back can do just as well with a shortened course of radiation therapy, researchers report. "We can treat patients with ...

A three-week course of radiation therapy is as safe and effective as four to six weeks of treatment for patients with early-stage breast cancer who have a higher risk of having their tumors recur, ...

LOS ANGELES, November 2, 2004 - Brachytherapy, the administration of radiation therapy locally through radioactive seeds, holds promise as part of a limb-sparing treatment program for patients with ...

Long-term results from a phase 3 study showed that adding a focal boost to standard external beam radiotherapy (EBRT) improved 10-year biochemical disease-free survival (DFS) and reduced biochemical ...

A new study led by researchers from the UCLA Health Jonsson Comprehensive Cancer Center shows that using high doses of radiation while integrating an ablative radiotherapy technique called ...

Accuray Incorporated ARAY recently unveiled an online adaptive therapy option, Cenos, for its Radixact System. The solution was unveiled, in partnership with Limbus AI, at the ongoing 2023 ASTRO ...

Please provide your email address to receive an email when new articles are posted on . A 3-week course of hypofractionated whole-breast radiation therapy appeared as safe and effective as a ...

An early-phase, dose-escalation study of a hypofractionated approach to concurrent chemoradiation using an an adaptive stereotactic ablative radiotherapy (SABR) boost showed promising results in ...

Research suggests that children with average risk medulloblastoma can receive radiation to a smaller volume of the brain at the end of a six-week course of treatment and still maintain the same ...